PCN114 Real-World Healthcare Costs Of Late-Line Multiple Myeloma (MM) Patients On Common Monotherapies: A German Claims Data Analysis

Abstract

Authors

Z. Kocaata T. Wilke F. Fischer R. Welte H. Einsele

Full Text Cite This Article
Back to Volume 23, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×